Doyle et al. demonstrated matrix metalloproteinase 7 (MMP-7), pulmonary and activation-related chemokine (PARC), and surfactant-protein D (SP-D) effectively predicted ILD in patients with rheumatoid arthritis (RA) when modeled with clinical characteristics (84). The gene discussed is SFTPD; the disease is interstitial lung disease.